India’s knees are in trouble—literally. With over 6 crore people diagnosed with osteoarthritis every year and 2.5 lakh knee replacement surgeries annually, knee health has become a national concern. Yet, most people don’t realize their knees are failing them until it’s too late. That’s where Ashva steps in—a groundbreaking startup that’s revolutionizing knee health with AI-powered medical devices designed for early diagnosis and better recovery.
The driving force behind Ashva is Anmol Ajay Saxena, an entrepreneur whose passion for knee health is deeply personal. Her struggles with knee pain during a college weight-loss journey, combined with watching her mother suffer through eight years of chronic knee issues and physiotherapy, fueled her determination to create a solution. Unlike many of her peers who pursued stable jobs, Anmol took the unconventional path—turning her college hackathon idea into a real-world product. After earning and saving money at Ford Motors, she quit her job after 2.5 years to dive headfirst into research. Meeting 75 physiotherapists, orthopedic surgeons, and observing 30+ live surgeries, she ensured that her product met real-world medical needs.
Her brainchild, Fitknees, is an AI-powered wearable device that diagnoses knee health in just 10 minutes. Designed for use in hospitals and physiotherapy centers, it comes with four motion sensors, a charging dock, and a tablet, offering a seamless and accurate diagnostic experience. To enhance its capabilities, Fitknees is paired with Fitmust, another device that provides a more comprehensive muscle assessment. Together, the two devices are priced at ₹7.5 lakh, while Fitmust alone costs ₹85,000. Despite its premium pricing, Ashva’s technology has been rapidly adopted by over 115+ orthopedic hospitals, including Apollo, Manipal, and Aster Hospitals.
When Anmol took the Shark Tank India stage, she came prepared, asking for ₹50 lakh in exchange for 1.25% equity, valuing Ashva at ₹40 crore. The sharks were intrigued by the product’s potential but also concerned about its scalability. One by one, Peyush Bansal, Anupam Mittal, Namita Thapar, and Kunal Shah bowed out. But just as it seemed the deal might slip away, Vinita Singh saw the bigger picture. She recognized the massive untapped potential in the knee health industry and stepped up with an offer—₹50 lakh for 4% equity. Understanding the value of mentorship and strategic support, Anmol accepted the deal, securing the backing she needed to take Ashva to new heights.
With Vinita’s investment and guidance, Ashva is poised to become a game-changer in India’s orthopedic care. From a college hackathon idea to a trusted medical solution in top hospitals, Anmol’s journey is proof that passion, persistence, and innovation can transform not just a career, but an entire industry. As Ashva expands, it’s not just helping knees—it’s helping millions take confident steps toward a healthier future.
